Why Kiniksa Pharmaceuticals International Plc (KNSA) Stock Is Rising
As of 2026-07-28, Kiniksa Pharmaceuticals International Plc (KNSA) has a next-year EPS growth estimate of 39.66%. Featured in our EPS revision report on 2026-07-28.
Why KNSA Stock Is Rising
- +EPS Estimate Upgraded: Analysts raised Kiniksa Pharmaceuticals International Plc's next-year EPS growth estimate from 39.51% to 39.66% on 2026-07-23.
- ·Current-Year Growth: Projected at 80.79%, supporting the forward estimate revision.
News Context
The primary driver is the July 23 upgrade to next-year EPS growth estimates, now at 39.66%, reflecting increased analyst confidence. No recent headlines identify a specific catalyst such as an earnings beat or guidance raise; the next quarterly report is scheduled for July 28. The stock’s rise appears tied to this upward revision rather than a discrete event.
Generated 2026-07-28 · news as of 2026-07-28
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 39.66%
- EPS growth this year
- 80.79%
- EPS next quarter (est)
- $0.30
- Last price
- $78.84
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-07-28 | 39.66% | 80.79% | $0.30 | $78.84 |
| 2026-07-27 | 39.66% | 80.79% | $0.30 | $63.53 |
| 2026-07-26 | 39.66% | 80.79% | $0.30 | $62.84 |
| 2026-07-24 | 39.66% | 80.79% | $0.30 | $62.84 |
| 2026-07-23 | 39.66% | 80.79% | $0.30 | $63.05 |
| 2026-07-22 | 39.51% | 80.63% | $0.30 | $62.44 |
| 2026-07-21 | 39.51% | 80.63% | $0.30 | $63.55 |
| 2026-07-20 | 39.51% | 80.63% | $0.30 | $62.58 |
| 2026-07-19 | 39.51% | 80.63% | $0.30 | $63.95 |
| 2026-07-17 | 39.51% | 80.63% | $0.30 | $63.95 |
| 2026-07-16 | 39.51% | 80.63% | $0.30 | $61.11 |
| 2026-07-15 | 39.51% | 80.63% | $0.30 | $61.69 |
| 2026-07-14 | 39.51% | 80.63% | $0.30 | $61.98 |
| 2026-07-13 | 39.51% | 80.63% | $0.30 | $60.94 |
| 2026-07-12 | 39.51% | 80.63% | $0.30 | $63.44 |
| 2026-07-09 | 40.90% | 83.46% | $0.31 | $65.38 |
| 2026-07-08 | 40.90% | 83.46% | $0.31 | $64.76 |
| 2026-07-07 | 40.90% | 83.46% | $0.31 | $67.29 |
| 2026-07-06 | 40.90% | 83.46% | $0.31 | $62.77 |
| 2026-07-05 | 40.90% | 83.46% | $0.31 | $64.53 |
| 2026-07-02 | 40.90% | 83.46% | $0.31 | $64.53 |
| 2026-07-01 | 40.90% | 83.46% | $0.31 | $62.88 |
| 2026-06-30 | 40.90% | 83.46% | $0.31 | $63.95 |
| 2026-06-29 | 40.90% | 83.46% | $0.31 | $62.41 |
| 2026-06-28 | 39.55% | 82.96% | $0.31 | $59.20 |
| 2026-06-25 | 39.55% | 82.96% | $0.31 | $56.89 |
| 2026-06-24 | 39.55% | 82.96% | $0.31 | $59.13 |
| 2026-06-23 | 39.55% | 82.96% | $0.31 | $59.49 |
| 2026-06-22 | 39.55% | 82.96% | $0.31 | $57.13 |
| 2026-06-21 | 39.55% | 82.96% | $0.31 | $55.11 |
Reports Featuring KNSA
Recent News
Screen Performance
Aggregate stats across all 1888 tickers our top-EPS-revision screen has flagged over the past 118 days.
- Median return since detection
- +2.3%
- % of tickers in the green
- 54%
- Median return on winners
- +19.6%
- Large revisions captured
- 1134
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did Kiniksa Pharmaceuticals International Plc (KNSA) stock go up recently?▾
Kiniksa Pharmaceuticals International Plc (KNSA) stock has risen following an analyst upgrade of its next-year EPS growth estimate from 39.51% to 39.66% on 2026-07-23. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is Kiniksa Pharmaceuticals International Plc's next-year EPS growth estimate?▾
As of 2026-07-28, Kiniksa Pharmaceuticals International Plc (KNSA) has a next-year EPS growth estimate of 39.66%, based on analyst consensus.
When was the latest EPS estimate revision for KNSA?▾
The most recent revision occurred on 2026-07-23, when analysts adjusted the next-year EPS growth estimate from 39.51% to 39.66%.
What sector and industry does Kiniksa Pharmaceuticals International Plc belong to?▾
Kiniksa Pharmaceuticals International Plc operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. KNSA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Kiniksa Pharmaceuticals International Plc (KNSA) appears here because it was detected by our daily top-EPS-revision-performer screen.